EUCTR2005-002494-75-GB进行中（未招募）1 期
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.
Servier Research and Development Ltd. (S.R.D.L) (for UK only)0 个研究点目标入组 1,680 人开始时间: 2006年1月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,680
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- Caucasian men and women aged = 50 years,
- •- Primary knee osteoarthritis of the medial femoro-tibial compartment,
- •- Under effective contraceptive method for non-menopausal women,
- •- Ambulatory (able to walk unassisted),
- •- Capable of understanding the study, capable of reading and writing,
- •- Patients having given written informed consent for this study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Conditions depending on the patient (detailed in the study protocol)
- •- Significant medical history or concomitant diseases (detailed in the study protocol)
- •- Previous treatments likely to have actions on cartilage metabolism (detailed in the study protocol)
- •- Previous treatments which could compromise the clinical assessment (detailed in the study protocol).
研究者
相似试验
进行中（未招募）
不适用
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study. - POLKAOsteoarthritisEUCTR2005-002494-75-DKInstitut de Recherches Internationales Servier1,680
进行中（未招募）
不适用
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.MedDRA version: 7.0Level: PTClassification code 10031161OsteoarthritisEUCTR2005-002494-75-ATInstitut de Recherches Internationales Servier1,680
进行中（未招募）
不适用
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 2 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.MedDRA version: 7.0Level: PTClassification code 10031161OsteoarthritisEUCTR2005-002494-75-EEInstitut de Recherches Internationales Servier2,118
进行中（未招募）
不适用
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 2 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.MedDRA version: 7.0Level: PTClassification code 10031161OsteoarthritisEUCTR2005-002494-75-ESServier S.L.960
进行中（未招募）
不适用
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.OSTEOARTHRITISMedDRA version: 14.1Level: PTClassification code 10031161Term: OsteoarthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2005-002494-75-ITINSTITUT DE RECHERCHES INTERNATIONALES SERVIER960